Fractionated stereotactic radiotherapy for acoustic neuroma : Single-institution experience at the princess margaret hospital (pages 1203–1210)
Eng-Siew Koh, Barbara-Ann Millar, Cynthia Ménard, Howard Michaels, Mostafa Heydarian, Shenaz Ladak, Sharon McKinnon, John A. Rutka, Abhijit Guha, Gregory R. Pond and Normand J. Laperriere
Version of Record online: 22 FEB 2007 | DOI: 10.1002/cncr.22499
A retrospective review of fractionated stereotactic radiotherapy (FSRT) for acoustic neuroma assessed the clinical outcome and toxicity in 60 consecutive patients. At a median follow-up of 31.9 months the 5-year actuarial local control rate was 96.2% (95% CI: 91.1%–100.0%). The overall hearing preservation was 77.3%, with no new cases of cranial nerve toxicity post-FSRT reported. FSRT remains a safe and effective alternative treatment modality for acoustic neuroma compared with either microsurgical resection or single fraction stereotactic radiosurgery.